Loading…
Loading…
Ref. No.
Tender Value
₹7.6 L
EMD Value
Exempted
Closing Date
18 May 2026, 9:00 amClosed
ECHS RE 03
9269000
GEM/2026/B/7485668
Two Packet Bid
Atorvastatin 20 Mg Plus Aspirin 75 Mg PlusClopidogrel 75 mg Tab,Dressing first aid,Buspirone 10 Mg
Ganganagar, Rajasthan
Total value wise evaluation
BOQ
6 documents required · 6 mandatory
3 yrs
₹3 L
₹20 L
50%
Exempted
Yes
15 May 2026
4 May 2026
18 May 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Atorvastatin 20 Mg Plus Aspirin 75 Mg PlusClopidogrel 75 mg Tab | 1,500 | No | MEDSTORENCO | 15 |
| 2 | Dressing first aid | 100 | No | MEDSTORENCO | 15 |
| 3 | Buspirone 10 Mg Tab | 600 | No | MEDSTORENCO | 15 |
| 4 | Bisoprolol 2 Point 5 mg Tab | 1,800 | No | MEDSTORENCO | 15 |
| 5 | Carbamazapine 200 mg Tab | 400 | No | MEDSTORENCO | 15 |
| 6 | Clinidipine 10 Mg Tab | 4,200 | No | MEDSTORENCO | 15 |
| 7 | Clinidipine 20 Mg Tab | 850 | No | MEDSTORENCO | 15 |
| 8 | Calcium Dobesilate 500 Mg Tab | 300 | No | MEDSTORENCO | 15 |
| 9 | Cap Nuhenz Methylcobalamin 1500 mcg Plus Alpha Lipoic Acid 100 mg Plus Myo Inositol 100 mg Plus Folic Acid 1Point 5 mg Plus Chromium Picolinate 200 mcg Plus Selenium 55 mcg Plus Benfotiamine 150mg | 300 | No | MEDSTORENCO | 15 |
| 10 | Tab Trypsin 48 Plus Bromelain 90 Plus Rutoside 100 Plus Diclofenac 50 mg | 2,400 | No | MEDSTORENCO | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9269000.pdf
GEM_BID • 0.63 MB
re-03_-1_2026-04-28-18-39-09_185b2cf0711e9380167648dcbef468dd.pdf
BOQ • 0.05 MB
boq_item_sample_file_-3_2026-04-28-18-39-09_1f007248f2191361c1904caefbc627a6.csv
BOQ • 0.01 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .